Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorJewish General Hospital
About this trial
A randomized, controlled, double-blinded clinical trial evaluating the effect of the administration of a Maltodextrin solution on cardiac function in patients presenting for coronary artery bypass grafting surgery with a reduced left ventricular ejection fraction.
Eligibility criteria
Qualifiers
18 years of age or older
Presenting for coronary artery bypass grafting surgery
Preoperative left ventricular ejection fraction < 50%
First case of the day (7:30am start time)
Disqualifiers
Dysphagia, gastroparesis
Cannot tolerate oral intake
Celiac disease
Type 1 diabetes
Trial design
Treatments tested in this trial
- Maltodextrin solution
- Placebo solution
Treatment groups
70 Participants
are divided into 2 treatment groupsLocations
1Jewish General HospitalH3T1E2, MontrealQuebec, Canada
Sponsors and collaborators
Jewish General Hospital
Lead sponsor
Source ClinicalTrials.gov